Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide
- PMID: 7508746
- DOI: 10.1021/bi00172a012
Catalytically distinct conformations of the ribonuclease H of HIV-1 reverse transcriptase by substrate cleavage patterns and inhibition by azidothymidylate and N-ethylmaleimide
Abstract
The RNase H activity of recombinant HIV-1 reverse transcriptase (RT) has been characterized with respect to inhibition by azidothymidylate (AZTMP) and N-ethylmaleimide (NEM) and to cleavage patterns using either poly(rA)/poly(dT) or poly(rG)/poly(dC) as model substrate and either Mg2+ or Mn2+ as divalent cation activator. The inhibitory potency of AZTMP and other nucleotide analogues was found to be dependent on both the composition of the substrate and the divalent cation. The enzyme was significantly more sensitive to AZTMP inhibition with poly(rG)/poly(dC) than with poly(rA)/poly(dT) as substrate and in Mn2+ than in Mg2+ with either substrate. Kinetic studies indicated that AZTMP is a competitive inhibitor with respect to the substrate in Mn2+ whereas it behaves as an uncompetitive inhibitor in Mg2+. These results suggest that the enzyme may exist in two distinct forms depending on whether Mg2+ or Mn2+ is the divalent cation activator. Consistent with this suggestion is the alteration in the mode of cleavage of the substrate upon substitution of Mg2+ with Mn2+. In Mg2+, hydrolysis of poly(rA)/poly(dT) appears to be solely endonucleolytic, whereas in Mn2+, hydrolysis is both endonucleolytic and exonucleolytic. With poly(rG)/poly(dC) as substrate, hydrolysis is both endonucleolytic and exonucleolytic in either Mg2+ or Mn2+. There is a positive correlation between sensitivity to AZTMP and production of mononucleotides, suggesting that the exonuclease activity of RNase H is preferentially inhibited by AZTMP. The sensitivity of RNase H to inhibition by N-ethylmaleimide was also found to be markedly influenced by the substrate composition and the divalent cation activator, being most sensitive under conditions in which endonucleolytic activity predominates.(ABSTRACT TRUNCATED AT 250 WORDS)
Similar articles
-
Inhibition of the RNase H activity of HIV reverse transcriptase by azidothymidylate.Biochemistry. 1991 May 21;30(20):4831-5. doi: 10.1021/bi00234a001. Biochemistry. 1991. PMID: 1709809
-
Characterization of the p68/p58 heterodimer of human immunodeficiency virus type 2 reverse transcriptase.Biochemistry. 1996 Feb 13;35(6):1911-7. doi: 10.1021/bi9516440. Biochemistry. 1996. PMID: 8639674
-
Dissecting the effects of DNA polymerase and ribonuclease H inhibitor combinations on HIV-1 reverse-transcriptase activities.Biochemistry. 2005 Feb 8;44(5):1595-606. doi: 10.1021/bi0486740. Biochemistry. 2005. PMID: 15683243
-
Human immunodeficiency virus reverse transcriptase. Substrate and inhibitor kinetics with thymidine 5'-triphosphate and 3'-azido-3'-deoxythymidine 5'-triphosphate.J Biol Chem. 1990 Nov 25;265(33):20302-7. J Biol Chem. 1990. PMID: 1700787
-
RNase H activity associated with reverse transcriptase from feline immunodeficiency virus.J Virol. 1992 Feb;66(2):1215-8. doi: 10.1128/JVI.66.2.1215-1218.1992. J Virol. 1992. PMID: 1370549 Free PMC article.
Cited by
-
Targeting Metalloenzymes for Therapeutic Intervention.Chem Rev. 2019 Jan 23;119(2):1323-1455. doi: 10.1021/acs.chemrev.8b00201. Epub 2018 Sep 7. Chem Rev. 2019. PMID: 30192523 Free PMC article. Review.
-
Specific initiation and switch to elongation of human immunodeficiency virus type 1 reverse transcription require the post-transcriptional modifications of primer tRNA3Lys.EMBO J. 1996 Feb 15;15(4):917-24. EMBO J. 1996. PMID: 8631312 Free PMC article.
-
Unblocking of chain-terminated primer by HIV-1 reverse transcriptase through a nucleotide-dependent mechanism.Proc Natl Acad Sci U S A. 1998 Nov 10;95(23):13471-6. doi: 10.1073/pnas.95.23.13471. Proc Natl Acad Sci U S A. 1998. PMID: 9811824 Free PMC article.
-
The amphiphilic properties of novenamines determine their activity as inhibitors of HIV-1 RNase H.Experientia. 1996 Apr 15;52(4):329-35. doi: 10.1007/BF01919535. Experientia. 1996. PMID: 8620935
-
Mechanisms of nucleoside analog antiviral activity and resistance during human immunodeficiency virus reverse transcription.Antimicrob Agents Chemother. 1996 Mar;40(3):527-40. doi: 10.1128/AAC.40.3.527. Antimicrob Agents Chemother. 1996. PMID: 8851566 Free PMC article. Review. No abstract available.
MeSH terms
Substances
LinkOut - more resources
Other Literature Sources